| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 54 | 2020 | 1462 | 5.590 |
Why?
|
| Polymorphism, Single Nucleotide | 65 | 2019 | 1066 | 5.240 |
Why?
|
| African Americans | 62 | 2018 | 1424 | 5.110 |
Why?
|
| Genome-Wide Association Study | 51 | 2019 | 549 | 3.470 |
Why?
|
| Genetic Predisposition to Disease | 39 | 2019 | 835 | 3.440 |
Why?
|
| Diabetic Nephropathies | 14 | 2020 | 227 | 2.460 |
Why?
|
| Lipoproteins, HDL | 18 | 2018 | 252 | 2.430 |
Why?
|
| Apolipoproteins | 16 | 2016 | 200 | 2.370 |
Why?
|
| Kidney Failure, Chronic | 17 | 2020 | 543 | 2.350 |
Why?
|
| Genetic Variation | 15 | 2018 | 246 | 2.270 |
Why?
|
| Insulin Resistance | 20 | 2018 | 469 | 2.070 |
Why?
|
| Adiponectin | 8 | 2017 | 103 | 1.590 |
Why?
|
| Atherosclerosis | 15 | 2018 | 788 | 1.580 |
Why?
|
| European Continental Ancestry Group | 27 | 2019 | 1163 | 1.470 |
Why?
|
| Genotype | 32 | 2019 | 731 | 1.470 |
Why?
|
| Middle Aged | 72 | 2019 | 12125 | 1.390 |
Why?
|
| Genetic Loci | 15 | 2019 | 146 | 1.320 |
Why?
|
| Hispanic Americans | 18 | 2019 | 930 | 1.310 |
Why?
|
| Male | 81 | 2019 | 19641 | 1.250 |
Why?
|
| Female | 80 | 2019 | 20261 | 1.220 |
Why?
|
| Insulin | 8 | 2018 | 367 | 1.210 |
Why?
|
| Humans | 108 | 2020 | 32798 | 1.210 |
Why?
|
| Membrane Proteins | 10 | 2019 | 251 | 1.210 |
Why?
|
| Blood Glucose | 12 | 2018 | 494 | 1.100 |
Why?
|
| Adult | 50 | 2019 | 9560 | 1.030 |
Why?
|
| Gene Frequency | 16 | 2018 | 220 | 1.010 |
Why?
|
| Aged | 51 | 2019 | 10538 | 0.990 |
Why?
|
| Mexican Americans | 5 | 2019 | 60 | 0.920 |
Why?
|
| Adiposity | 7 | 2017 | 198 | 0.920 |
Why?
|
| Brain | 7 | 2018 | 946 | 0.900 |
Why?
|
| Renal Insufficiency, Chronic | 6 | 2020 | 297 | 0.890 |
Why?
|
| Obesity | 9 | 2017 | 1152 | 0.890 |
Why?
|
| Case-Control Studies | 19 | 2018 | 876 | 0.860 |
Why?
|
| Kidney Diseases | 6 | 2016 | 250 | 0.850 |
Why?
|
| Cognition Disorders | 5 | 2018 | 370 | 0.840 |
Why?
|
| Genetic Association Studies | 12 | 2019 | 148 | 0.810 |
Why?
|
| Phenotype | 12 | 2019 | 638 | 0.780 |
Why?
|
| Lipids | 5 | 2019 | 229 | 0.720 |
Why?
|
| Alleles | 10 | 2017 | 253 | 0.720 |
Why?
|
| Albuminuria | 8 | 2020 | 180 | 0.720 |
Why?
|
| Quantitative Trait Loci | 5 | 2019 | 141 | 0.680 |
Why?
|
| Glucose | 3 | 2018 | 184 | 0.630 |
Why?
|
| Mutation, Missense | 2 | 2014 | 51 | 0.630 |
Why?
|
| Cohort Studies | 18 | 2018 | 1844 | 0.630 |
Why?
|
| Vitamin D | 4 | 2018 | 189 | 0.610 |
Why?
|
| Cognition | 6 | 2017 | 551 | 0.570 |
Why?
|
| Body Mass Index | 8 | 2018 | 908 | 0.560 |
Why?
|
| Lipase | 3 | 2019 | 28 | 0.520 |
Why?
|
| Tissue Donors | 3 | 2016 | 207 | 0.520 |
Why?
|
| Risk Factors | 15 | 2018 | 3974 | 0.520 |
Why?
|
| Adipose Tissue | 3 | 2017 | 349 | 0.510 |
Why?
|
| Fibroblast Growth Factors | 2 | 2017 | 35 | 0.500 |
Why?
|
| Glomerulonephritis | 2 | 2018 | 19 | 0.490 |
Why?
|
| Young Adult | 16 | 2019 | 2730 | 0.480 |
Why?
|
| Kidney Transplantation | 4 | 2016 | 512 | 0.470 |
Why?
|
| Glomerular Filtration Rate | 9 | 2020 | 309 | 0.460 |
Why?
|
| PPAR gamma | 1 | 2014 | 44 | 0.430 |
Why?
|
| Cross-Sectional Studies | 11 | 2018 | 1572 | 0.430 |
Why?
|
| Haplotypes | 8 | 2015 | 220 | 0.430 |
Why?
|
| Epistasis, Genetic | 4 | 2018 | 44 | 0.430 |
Why?
|
| Blood Pressure | 7 | 2018 | 862 | 0.420 |
Why?
|
| Cation Transport Proteins | 1 | 2014 | 24 | 0.420 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2019 | 47 | 0.420 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2013 | 2 | 0.420 |
Why?
|
| Molecular Motor Proteins | 3 | 2014 | 58 | 0.420 |
Why?
|
| Graft Survival | 2 | 2016 | 313 | 0.420 |
Why?
|
| Hypertension | 7 | 2018 | 976 | 0.420 |
Why?
|
| Myosin Heavy Chains | 3 | 2014 | 89 | 0.420 |
Why?
|
| Adipocytes | 1 | 2014 | 84 | 0.420 |
Why?
|
| Fasting | 4 | 2017 | 94 | 0.410 |
Why?
|
| Continental Population Groups | 4 | 2019 | 236 | 0.400 |
Why?
|
| Lipid Metabolism | 3 | 2019 | 105 | 0.390 |
Why?
|
| African Continental Ancestry Group | 6 | 2019 | 363 | 0.390 |
Why?
|
| Metabolome | 2 | 2018 | 37 | 0.390 |
Why?
|
| Adolescent | 14 | 2019 | 3638 | 0.390 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2018 | 1307 | 0.380 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2018 | 65 | 0.370 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2015 | 154 | 0.370 |
Why?
|
| Cell Differentiation | 1 | 2014 | 467 | 0.370 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2013 | 70 | 0.360 |
Why?
|
| Family | 4 | 2018 | 115 | 0.360 |
Why?
|
| Linkage Disequilibrium | 5 | 2019 | 185 | 0.340 |
Why?
|
| Gene Expression Regulation | 5 | 2016 | 475 | 0.340 |
Why?
|
| Homeostasis | 5 | 2018 | 135 | 0.340 |
Why?
|
| Bone Density | 4 | 2015 | 203 | 0.330 |
Why?
|
| Sequence Analysis, DNA | 4 | 2017 | 135 | 0.330 |
Why?
|
| Aged, 80 and over | 10 | 2019 | 4032 | 0.320 |
Why?
|
| Nerve Tissue Proteins | 3 | 2019 | 117 | 0.310 |
Why?
|
| Aspartate Aminotransferases | 1 | 2019 | 28 | 0.310 |
Why?
|
| Alanine Transaminase | 1 | 2019 | 46 | 0.310 |
Why?
|
| Transcription Factors | 4 | 2019 | 176 | 0.300 |
Why?
|
| Lod Score | 5 | 2017 | 73 | 0.300 |
Why?
|
| Triglycerides | 5 | 2019 | 228 | 0.300 |
Why?
|
| United States | 9 | 2018 | 4108 | 0.290 |
Why?
|
| Receptor, Melatonin, MT2 | 1 | 2018 | 4 | 0.280 |
Why?
|
| Glaucoma, Open-Angle | 2 | 2018 | 22 | 0.280 |
Why?
|
| Lupus Nephritis | 1 | 2018 | 30 | 0.280 |
Why?
|
| Kidney Function Tests | 5 | 2019 | 107 | 0.280 |
Why?
|
| Liver | 4 | 2019 | 492 | 0.270 |
Why?
|
| Smoking | 3 | 2019 | 531 | 0.270 |
Why?
|
| Fibrinolysis | 1 | 2017 | 7 | 0.270 |
Why?
|
| Models, Genetic | 2 | 2018 | 94 | 0.270 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2017 | 43 | 0.260 |
Why?
|
| INDEL Mutation | 1 | 2017 | 11 | 0.260 |
Why?
|
| Signal Transduction | 2 | 2016 | 686 | 0.260 |
Why?
|
| Laminin | 1 | 2016 | 13 | 0.250 |
Why?
|
| NFI Transcription Factors | 1 | 2016 | 13 | 0.250 |
Why?
|
| Islets of Langerhans | 2 | 2016 | 76 | 0.250 |
Why?
|
| Apolipoproteins E | 1 | 2016 | 87 | 0.250 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 1 | 2016 | 4 | 0.250 |
Why?
|
| Odds Ratio | 5 | 2017 | 467 | 0.240 |
Why?
|
| Alcohol Drinking | 2 | 2019 | 256 | 0.240 |
Why?
|
| Linear Models | 4 | 2019 | 445 | 0.240 |
Why?
|
| Blood Pressure Determination | 1 | 2016 | 102 | 0.240 |
Why?
|
| Creatinine | 4 | 2017 | 198 | 0.240 |
Why?
|
| Receptors, Cell Surface | 1 | 2016 | 69 | 0.240 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2015 | 7 | 0.240 |
Why?
|
| Muscles | 1 | 2016 | 63 | 0.240 |
Why?
|
| Parathyroid Hormone | 1 | 2016 | 47 | 0.240 |
Why?
|
| Coronary Disease | 1 | 2017 | 214 | 0.240 |
Why?
|
| Cardiovascular Diseases | 4 | 2017 | 1140 | 0.240 |
Why?
|
| Fatty Liver | 2 | 2013 | 66 | 0.230 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2015 | 9 | 0.230 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 213 | 0.230 |
Why?
|
| Caveolin 1 | 1 | 2015 | 13 | 0.230 |
Why?
|
| Stress, Physiological | 1 | 2015 | 54 | 0.230 |
Why?
|
| Mutation | 1 | 2017 | 493 | 0.220 |
Why?
|
| Microsatellite Repeats | 1 | 2014 | 22 | 0.220 |
Why?
|
| Brain Diseases | 1 | 2014 | 38 | 0.210 |
Why?
|
| Neoplasm Proteins | 2 | 2013 | 145 | 0.210 |
Why?
|
| Open Reading Frames | 1 | 2014 | 20 | 0.210 |
Why?
|
| Selenoprotein P | 1 | 2013 | 2 | 0.210 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2013 | 24 | 0.210 |
Why?
|
| Autoantigens | 1 | 2013 | 16 | 0.210 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 142 | 0.210 |
Why?
|
| Renal Dialysis | 1 | 2016 | 280 | 0.200 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 71 | 0.200 |
Why?
|
| Dopamine | 1 | 2016 | 234 | 0.200 |
Why?
|
| Genetics, Population | 1 | 2013 | 31 | 0.200 |
Why?
|
| Asian Continental Ancestry Group | 4 | 2019 | 108 | 0.200 |
Why?
|
| Cholesterol, LDL | 4 | 2019 | 171 | 0.200 |
Why?
|
| Carotid Artery Diseases | 1 | 2013 | 116 | 0.190 |
Why?
|
| Ethnic Groups | 2 | 2016 | 474 | 0.190 |
Why?
|
| Osteoporosis | 1 | 2013 | 71 | 0.190 |
Why?
|
| Energy Metabolism | 2 | 2018 | 155 | 0.190 |
Why?
|
| Organ Size | 3 | 2018 | 219 | 0.190 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 98 | 0.180 |
Why?
|
| Calcinosis | 1 | 2012 | 146 | 0.180 |
Why?
|
| Vitamin D Deficiency | 2 | 2018 | 91 | 0.180 |
Why?
|
| Inflammation | 1 | 2015 | 536 | 0.180 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 524 | 0.180 |
Why?
|
| Coronary Artery Disease | 2 | 2013 | 413 | 0.170 |
Why?
|
| Multivariate Analysis | 3 | 2017 | 682 | 0.170 |
Why?
|
| Neuropsychological Tests | 3 | 2017 | 363 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2012 | 265 | 0.160 |
Why?
|
| Animals | 5 | 2017 | 7569 | 0.160 |
Why?
|
| Proportional Hazards Models | 3 | 2017 | 764 | 0.160 |
Why?
|
| Life Style | 3 | 2019 | 407 | 0.160 |
Why?
|
| Risk | 3 | 2016 | 315 | 0.160 |
Why?
|
| Body Weight | 1 | 2011 | 301 | 0.160 |
Why?
|
| Glucose Tolerance Test | 3 | 2017 | 125 | 0.150 |
Why?
|
| Mice | 3 | 2017 | 2511 | 0.150 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2018 | 11 | 0.150 |
Why?
|
| Cholesterol, HDL | 3 | 2019 | 175 | 0.140 |
Why?
|
| Mitochondrial Proteins | 1 | 2018 | 71 | 0.140 |
Why?
|
| Energy Intake | 1 | 2017 | 128 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 71 | 0.130 |
Why?
|
| Insulin-Secreting Cells | 2 | 2017 | 53 | 0.130 |
Why?
|
| Genome, Human | 2 | 2017 | 132 | 0.130 |
Why?
|
| Demography | 2 | 2017 | 110 | 0.120 |
Why?
|
| Chromosome Mapping | 3 | 2019 | 193 | 0.120 |
Why?
|
| Risk Assessment | 3 | 2017 | 1460 | 0.120 |
Why?
|
| Base Sequence | 2 | 2014 | 247 | 0.120 |
Why?
|
| Carrier Proteins | 2 | 2018 | 136 | 0.120 |
Why?
|
| Reproducibility of Results | 3 | 2018 | 767 | 0.120 |
Why?
|
| Body Size | 1 | 2015 | 34 | 0.120 |
Why?
|
| Coronary Vessels | 2 | 2017 | 164 | 0.120 |
Why?
|
| Claudins | 1 | 2015 | 8 | 0.110 |
Why?
|
| Atrophy | 2 | 2015 | 46 | 0.110 |
Why?
|
| Mutant Chimeric Proteins | 1 | 2014 | 5 | 0.110 |
Why?
|
| HLA-B27 Antigen | 1 | 2014 | 8 | 0.110 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2014 | 9 | 0.110 |
Why?
|
| HMGA2 Protein | 1 | 2014 | 13 | 0.110 |
Why?
|
| Ion Transport | 1 | 2014 | 5 | 0.110 |
Why?
|
| Proinsulin | 1 | 2014 | 11 | 0.110 |
Why?
|
| Physical Fitness | 1 | 2015 | 133 | 0.110 |
Why?
|
| Endoplasmic Reticulum | 1 | 2013 | 23 | 0.100 |
Why?
|
| Prediabetic State | 1 | 2014 | 72 | 0.100 |
Why?
|
| Hela Cells | 1 | 2013 | 80 | 0.100 |
Why?
|
| Mexico | 1 | 2013 | 72 | 0.100 |
Why?
|
| Graft Rejection | 1 | 2015 | 241 | 0.100 |
Why?
|
| Indians, North American | 1 | 2013 | 110 | 0.100 |
Why?
|
| Exercise | 1 | 2019 | 679 | 0.100 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 352 | 0.100 |
Why?
|
| Genetic Markers | 2 | 2013 | 125 | 0.100 |
Why?
|
| Gout | 1 | 2012 | 14 | 0.100 |
Why?
|
| Diabetes Complications | 2 | 2014 | 182 | 0.100 |
Why?
|
| Uric Acid | 1 | 2012 | 27 | 0.100 |
Why?
|
| Metabolomics | 2 | 2018 | 55 | 0.100 |
Why?
|
| Mice, Knockout | 1 | 2014 | 453 | 0.100 |
Why?
|
| Pedigree | 2 | 2018 | 140 | 0.100 |
Why?
|
| RNA, Messenger | 1 | 2013 | 498 | 0.090 |
Why?
|
| Enzymes | 1 | 2011 | 5 | 0.090 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 2284 | 0.090 |
Why?
|
| Introns | 2 | 2016 | 39 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2016 | 3438 | 0.080 |
Why?
|
| Time Factors | 2 | 2016 | 2183 | 0.080 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2019 | 11 | 0.080 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2018 | 5 | 0.070 |
Why?
|
| Proteins | 2 | 2017 | 142 | 0.070 |
Why?
|
| Intraocular Pressure | 2 | 2018 | 41 | 0.070 |
Why?
|
| Age Factors | 2 | 2016 | 1197 | 0.070 |
Why?
|
| Molecular Weight | 1 | 2017 | 42 | 0.070 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2017 | 17 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2017 | 59 | 0.070 |
Why?
|
| C-Peptide | 1 | 2017 | 30 | 0.070 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 68 | 0.060 |
Why?
|
| Public Health | 1 | 2017 | 89 | 0.060 |
Why?
|
| Heterozygote | 1 | 2016 | 61 | 0.060 |
Why?
|
| Computational Biology | 1 | 2017 | 94 | 0.060 |
Why?
|
| Minisatellite Repeats | 1 | 2016 | 9 | 0.060 |
Why?
|
| Disease Progression | 1 | 2018 | 594 | 0.060 |
Why?
|
| Phosphates | 1 | 2015 | 25 | 0.060 |
Why?
|
| Iliac Artery | 1 | 2015 | 48 | 0.060 |
Why?
|
| Factor XIII | 1 | 2015 | 3 | 0.060 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2015 | 5 | 0.060 |
Why?
|
| Carotid Arteries | 1 | 2015 | 101 | 0.060 |
Why?
|
| Serine Endopeptidases | 1 | 2015 | 18 | 0.060 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 40 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 292 | 0.060 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2016 | 97 | 0.060 |
Why?
|
| Lipoproteins, LDL | 1 | 2015 | 80 | 0.060 |
Why?
|
| Tissue and Organ Procurement | 1 | 2016 | 99 | 0.060 |
Why?
|
| Databases, Nucleic Acid | 1 | 2014 | 5 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2016 | 486 | 0.060 |
Why?
|
| Memory | 1 | 2016 | 191 | 0.060 |
Why?
|
| Stroop Test | 1 | 2014 | 5 | 0.060 |
Why?
|
| Prevalence | 1 | 2017 | 1002 | 0.060 |
Why?
|
| Donor Selection | 1 | 2015 | 36 | 0.060 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2015 | 57 | 0.060 |
Why?
|
| Systole | 2 | 2018 | 98 | 0.060 |
Why?
|
| Diastole | 2 | 2018 | 97 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 789 | 0.050 |
Why?
|
| Albumins | 1 | 2014 | 44 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2014 | 32 | 0.050 |
Why?
|
| Radiography | 1 | 2015 | 386 | 0.050 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2014 | 11 | 0.050 |
Why?
|
| Renin-Angiotensin System | 1 | 2015 | 178 | 0.050 |
Why?
|
| Complement Factor H | 1 | 2014 | 5 | 0.050 |
Why?
|
| Registries | 1 | 2016 | 315 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2015 | 240 | 0.050 |
Why?
|
| Europe | 2 | 2016 | 83 | 0.050 |
Why?
|
| Angiotensinogen | 1 | 2014 | 59 | 0.050 |
Why?
|
| Exons | 1 | 2014 | 52 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 316 | 0.050 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2013 | 13 | 0.050 |
Why?
|
| Databases, Genetic | 1 | 2014 | 40 | 0.050 |
Why?
|
| Incidence | 1 | 2017 | 1238 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 532 | 0.050 |
Why?
|
| DNA Mutational Analysis | 2 | 2016 | 71 | 0.050 |
Why?
|
| Founder Effect | 1 | 2013 | 5 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 199 | 0.050 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2013 | 8 | 0.050 |
Why?
|
| Lysophospholipase | 1 | 2013 | 5 | 0.050 |
Why?
|
| Lectins, C-Type | 1 | 2013 | 13 | 0.050 |
Why?
|
| Cause of Death | 1 | 2014 | 240 | 0.050 |
Why?
|
| Heart Diseases | 1 | 2014 | 116 | 0.050 |
Why?
|
| Osmolar Concentration | 1 | 2012 | 22 | 0.050 |
Why?
|
| DNA | 1 | 2014 | 218 | 0.050 |
Why?
|
| Early Diagnosis | 1 | 2012 | 60 | 0.050 |
Why?
|
| Sex Factors | 1 | 2013 | 675 | 0.050 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2011 | 3 | 0.040 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2011 | 4 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2011 | 20 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2013 | 252 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 947 | 0.040 |
Why?
|
| Prognosis | 1 | 2014 | 1544 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor B | 1 | 2019 | 6 | 0.040 |
Why?
|
| Inheritance Patterns | 1 | 2019 | 11 | 0.040 |
Why?
|
| Brazil | 1 | 2019 | 16 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 483 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 35 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 47 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2019 | 63 | 0.040 |
Why?
|
| ROC Curve | 1 | 2018 | 168 | 0.040 |
Why?
|
| Body Constitution | 1 | 2018 | 25 | 0.030 |
Why?
|
| Visual Fields | 1 | 2018 | 27 | 0.030 |
Why?
|
| Syndrome | 1 | 2017 | 74 | 0.030 |
Why?
|
| Drosophila | 1 | 2017 | 35 | 0.030 |
Why?
|
| Visual Acuity | 1 | 2018 | 76 | 0.030 |
Why?
|
| Cholesterol | 1 | 2019 | 253 | 0.030 |
Why?
|
| Finland | 1 | 2017 | 2 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2012 | 2327 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2016 | 18 | 0.030 |
Why?
|
| Sample Size | 1 | 2016 | 39 | 0.030 |
Why?
|
| Waist-Hip Ratio | 1 | 2015 | 35 | 0.030 |
Why?
|
| Research Design | 1 | 2018 | 331 | 0.030 |
Why?
|
| Alabama | 1 | 2015 | 41 | 0.030 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2015 | 5 | 0.030 |
Why?
|
| Genome | 1 | 2014 | 38 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2015 | 172 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2014 | 369 | 0.030 |
Why?
|
| Inhibins | 1 | 2012 | 4 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 894 | 0.020 |
Why?
|
| tRNA Methyltransferases | 1 | 2012 | 5 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2012 | 5 | 0.020 |
Why?
|
| ADAM Proteins | 1 | 2012 | 13 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 6 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 46 | 0.020 |
Why?
|
| Asia | 1 | 2011 | 19 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 459 | 0.020 |
Why?
|
| Africa | 1 | 2011 | 28 | 0.020 |
Why?
|
| Child | 1 | 2018 | 2478 | 0.020 |
Why?
|
| Colorado | 1 | 2010 | 42 | 0.020 |
Why?
|
| Texas | 1 | 2010 | 40 | 0.020 |
Why?
|
| North Carolina | 1 | 2015 | 1546 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2010 | 28 | 0.020 |
Why?
|
| Family Health | 1 | 2010 | 78 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 334 | 0.020 |
Why?
|
| Stroke | 1 | 2011 | 609 | 0.010 |
Why?
|